Skip to main content
Log in

Prevention of Lens Protein–, Endotoxin– , and Interleukin– 1– induced uveitis with chalcone derivatives

  • Published:
InflammoPharmacology Aims and scope Submit manuscript

Abstract

Yao Q-S, Varma RS, Liu SXL, Chiou GCY. Prevention of lens protein-, endotoxin-, and interleukin-1-induced uveitis with chalcone derivatives. Inflammopharmacology. 1994;2:401-409.

In order to develop potent non-steroidal anti-inflammatory agents, a new class of agents unrelated to those known to inhibit the arachidonate cascade were investigated. Most of the chalcone derivatives studied, including flavanone hydrazone (RCV/FLV 574), 2’-(o-hydroxyphenol)-5-phenylpyrazoline (RCV-556Pz), 2’-acetoxychalcone-iV-monoacetylhydrazone (RVC-576) and 7V-(o-hydroxybenzoyl) morpholine (RVC-570), inhibited lens protein-induced ocular inflammation effectively at a dose level of 1% (50 μ1 as did prednisolone. Flavanone hydrazone (RCV/FLV 574) was the only compound among all these derivatives which inhibited endotoxin- and interleukin-1 (IL-1)-induced uveitis at 3 mg/kg ip tid this being approximately 7-fold more potent than prednisolone at 20 mg/kg ip tid. It is concluded that a non-steroidal non-arachidonate-mediated potent anti-inflammatory agent based on this compound could be developed with IL-1 blocking activity. However, flavanone hydrazone was rather toxic at effective doses tested. Modification of the chemical structure to reduce its side-effects would, therefore seem essential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Masuda K. Anti-inflammatory agents: Non-steroidal anti-inflammatory drugs. In: Sears ML, ed. Pharmacology of the eye. New York: Springer-Verlag; 1984:539–51.

    Google Scholar 

  2. Braquet P. Handbook of PAF and PAF antagonists. Boca Raton, FL: CRC Press; 1991.

    Google Scholar 

  3. Melli M, Parente L. Cytokines and lipocortins in inflammation and differentiation. New York: Wiley-Liss; 1991.

    Google Scholar 

  4. Dawson MM. Lymphokines and interleukins. Boca Raton, FL: CRC Press; 1991.

    Google Scholar 

  5. Dinarello CA. Modalities for reducing interleukin-1 activity in disease. Trends Pharmacol Sci. 1993; 14:155–9.

    Article  PubMed  CAS  Google Scholar 

  6. Granowitz Ev, Porat R, Mier Jw, Pribble Jp, Stiles Dm, Bloedow Dc, Catalona MA, Wolff SM, Dinarello CA. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine. 1992;4:353–60.

    Article  PubMed  CAS  Google Scholar 

  7. Chiou GCY, Chang MS. Ocular inflammation induced by lens protein and its prevention with new agents. In: Bazan NG, ed. New trends in lipid mediators research. Lipid mediators in eye inflammation. Basel: Karger; 1990; 94–109.

    Google Scholar 

  8. Chiou GCY, Yao QS, Varma RS. Inhibition of ocular inflammation by chalcone derivatives and prednisolone. J Ocular Pharmacol. 1992;8:213–23.

    CAS  Google Scholar 

  9. Manna F, Chimenti F, Bolosco A, Cenicola ML, Amico MD, Parillo C, Rossi F, Marmo E. Anti-inflammatory, analgesic and antipyretic N-acetyl-2-pyrazolines and dihydrothienocoumarines. Eur J Med Chem. 1992;27:633–9.

    Article  CAS  Google Scholar 

  10. Kallay F, Janzso G, Koczar I. The reaction of flavanone with hydrazine. Tetrahedron. 1965;21:19–24.

    Article  CAS  Google Scholar 

  11. Kallay F, Janzso G, Koczar I. Thermal rearrangement of 2′-hydroxychalcone hydrazone and flavanone hydrazone derivatives. Tetrahedron. 1965;21:3037–41.

    Article  CAS  Google Scholar 

  12. Miyano K, Chiou GCY. Pharmacological prevention of ocular inflammation induced by lens proteins. Ophth Res. 1984; 16:256–63.

    CAS  Google Scholar 

  13. Chiou GCY, Chang MS. Ocular inflammation induced by lens protein and its prevention with new agents (Review). In: Bazan NG, ed. New trends in lipid mediators research. Lipid mediators in eye inflammation. Basel: Karger; 1990: 94–10.

    Google Scholar 

  14. Chiou GCY, Yao QS, Li BHP. Inhibition of lens protein-, endotoxin-, and interleukin-1-induced ocular inflammation with osthole and some other non-steroidal anti-inflammatory agents. Inflammopharmacology. 1993;2:5–13.

    Article  Google Scholar 

  15. Chiou LY, Chiou GCY. Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit. J Ocular Pharmacol. 1985;l:383–90.

    Google Scholar 

  16. Dziezyc J, Millichamp NJ, Rodhe BH, Baker JS, Chiou GCY. Effects of lipoxygenase inhibitors in a model of lens-induced uveitis in the dog. Am J Vet Res. 1989;50:1877–82.

    PubMed  CAS  Google Scholar 

  17. Chang MS, Chiou GY. Prevention of lens protein induced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors. J Ocular Pharmacol. 1989;5:353–60.

    Article  CAS  Google Scholar 

  18. Chuang CY, Xiao JG, Chiou GCY. Ocular anti-inflammatory actions of matrine. J Ocular Pharmacol. 1987;3:129–34.

    CAS  Google Scholar 

  19. Chiou GCY, Shen ZF, Zhao F. Treatment and prevention of ocular inflammation with Chinese herbs. Int J Oriental Med. 1991;16:144–50.

    Google Scholar 

  20. Chang MS, Ziao JG, Chiou GCY. Prevention of ocular inflammation by matrine, prednisolone, and cyclooxygenase and lipoxygenase inhibitors. Acta Pharmacol Sinica. 1991;12:121–5.

    CAS  Google Scholar 

  21. Yao QS, Chiou GCY. Inhibition of crystallin-induced inflammation in rabbit eyes with five phytogenic compounds. Acta Pharmacol Sinica. 1993;14:13–7.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yao, Q.S., Varma, R.S., Liu, S.X.L. et al. Prevention of Lens Protein–, Endotoxin– , and Interleukin– 1– induced uveitis with chalcone derivatives. Inflammopharmacology 2, 401–409 (1994). https://doi.org/10.1007/BF02678606

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02678606

Keywords

Navigation